US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK [1 min]
03/12/2019
This video from January is US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK - “dictated” via our “primary payer” system
Dispatches discovers how Donald Trump’s allies and US drug giants want to force the NHS to pay more for US medicines [1 min]
28/10/2019
Tahir Amin is a British lawyer based in America who is an expert on drug pricing and on previous trade negotiations.
Medical products are ‘particularly vulnerable to severe extended delays’ ... - confirming our concerns (British Medical Association)
11/09/2019
The Operation Yellowhammer document states that medicines and medical products are ‘particularly vulnerable to severe extended delays’ in the event of a no deal Brexit - confirming our concerns as outlined in our briefing document last week